en

PRODUCT DETAIL

Lupkynis 7,9 mg mäkké kapsuly

Code 2176E
MA number EU/1/22/1678/001
Product Form: cps mol 180x7,9 mg (blis.Al/PVC)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AD Calcineurin inhibitors
L04AD03 Voclosporin
Shelf life: 36
Container: blister Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.09.2022
Validity: 15.09.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 06.10.2022
eu-flag.png sk-flag.png